Kukulka MJ - Search Results

1

Measurement of liver microsomal cytochrome p450 (CYP2D6) activity using [O-methyl-14C]dextromethorphan.

Rodrigues AD, Kukulka MJ, Surber BW, Thomas SB, Uchic JT, Rotert GA, Michel G, Thome-Kromer B, Machinist JM. Rodrigues AD, et al. Among authors: kukulka mj. Anal Biochem. 1994 Jun;219(2):309-20. doi: 10.1006/abio.1994.1271. Anal Biochem. 1994. PMID: 8080088

2

In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.

Rodrigues AD, Mulford DJ, Lee RD, Surber BW, Kukulka MJ, Ferrero JL, Thomas SB, Shet MS, Estabrook RW. Rodrigues AD, et al. Among authors: kukulka mj. Drug Metab Dispos. 1995 Jul;23(7):765-75. Drug Metab Dispos. 1995. PMID: 7587966

3

[O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.

Rodrigues AD, Kukulka MJ, Roberts EM, Ouellet D, Rodgers TR. Rodrigues AD, et al. Among authors: kukulka mj. Drug Metab Dispos. 1996 Jan;24(1):126-36. Drug Metab Dispos. 1996. PMID: 8825200

4

In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.

Rodrigues AD, Kukulka MJ, Ferrero JL, Cashman JR. Rodrigues AD, et al. Among authors: kukulka mj. Drug Metab Dispos. 1995 Oct;23(10):1143-52. Drug Metab Dispos. 1995. PMID: 8654204

5

In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite.

Machinist JM, Kukulka MJ, Bopp BA. Machinist JM, et al. Among authors: kukulka mj. Clin Pharmacokinet. 1995;29 Suppl 2:34-41. doi: 10.2165/00003088-199500292-00006. Clin Pharmacokinet. 1995. PMID: 8620669

6

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

Kempf DJ, Marsh KC, Kumar G, Rodrigues AD, Denissen JF, McDonald E, Kukulka MJ, Hsu A, Granneman GR, Baroldi PA, Sun E, Pizzuti D, Plattner JJ, Norbeck DW, Leonard JM. Kempf DJ, et al. Among authors: kukulka mj. Antimicrob Agents Chemother. 1997 Mar;41(3):654-60. doi: 10.1128/AAC.41.3.654. Antimicrob Agents Chemother. 1997. PMID: 9056009 Free PMC article.

7

Development of Dexlansoprazole Delayed-Release Capsules, a Dual Delayed-Release Proton Pump Inhibitor.

Grady H, Murakawa Y, Mulford D, Kukulka M. Grady H, et al. J Pharm Sci. 2019 Nov;108(11):3496-3501. doi: 10.1016/j.xphs.2019.07.023. Epub 2019 Aug 3. J Pharm Sci. 2019. PMID: 31386865 Review.

8

Pharmacokinetics and safety of dexlansoprazole MR in adolescents with symptomatic GERD.

Kukulka M, Wu J, Perez MC. Kukulka M, et al. J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):41-7. doi: 10.1097/MPG.0b013e31822a323a. J Pediatr Gastroenterol Nutr. 2012. PMID: 21716130 Clinical Trial.

9

Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration.

Kukulka M, Nudurupati S, Perez MC. Kukulka M, et al. Clin Exp Gastroenterol. 2017 Feb 17;10:47-56. doi: 10.2147/CEG.S121129. eCollection 2017. Clin Exp Gastroenterol. 2017. PMID: 28255251 Free PMC article.

10

Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule.

Kukulka M, Nudurupati S, Perez MC. Kukulka M, et al. Therap Adv Gastroenterol. 2016 Nov;9(6):770-780. doi: 10.1177/1756283X16666800. Epub 2016 Sep 25. Therap Adv Gastroenterol. 2016. PMID: 27803732 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page